Literature DB >> 9007415

Disablement observed, addressed, and experienced: integrating subjective experience into disablement models.

D J Peters1.   

Abstract

Although subjective experience is critical to full comprehension of disablement, it has yet to be integrated into models in a systematic and theoretically grounded way. This article presents a framework for modelling disablement that includes both objective and subjective features. The framework is based on a novel integration of: (1) perspectives on disablement; (2) the contexts within which disablement occurs; and (3) interaction among these perspectives and contexts. The framework is developed using nomenclature derived from the WHO's International Classification of Impairments, Disabilities, and Handicaps (ICIDH). Although ICIDH terminology is used, the article's integration of ideas can as well be applied to other disablement nomenclatures and models. The framework offers a conceptual background for innovative clinical, policy, and research responses to disablement, as well as for further development of disablement theory and models.

Mesh:

Year:  1996        PMID: 9007415     DOI: 10.3109/09638289609166320

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  3 in total

1.  Physical activity for people with a disability: a conceptual model.

Authors:  Hidde P van der Ploeg; Allard J van der Beek; Luc H V van der Woude; Willem van Mechelen
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

2.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

3.  The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis.

Authors:  J Fransen; D Uebelhart; G Stucki; T Langenegger; M Seitz; B A Michel
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.